Cathay Cost Of Revenue vs Net Income Analysis

688065 Stock

48.68 1.24 2.61%

Cathay Biotech financial indicator trend analysis is way more than just evaluating Cathay Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cathay Biotech is a good investment. Please check the relationship between Cathay Biotech Cost Of Revenue and its Net Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cost Of Revenue vs Net Income

Cost Of Revenue vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cathay Biotech Cost Of Revenue account and Net Income. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Cathay Biotech's Cost Of Revenue and Net Income is -0.24. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Net Income in the same time period over historical financial statements of Cathay Biotech, assuming nothing else is changed. The correlation between historical values of Cathay Biotech's Cost Of Revenue and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Cathay Biotech are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Cost Of Revenue i.e., Cathay Biotech's Cost Of Revenue and Net Income go up and down completely randomly.

Correlation Coefficient

-0.24

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Cathay Biotech income statement and represents the costs associated with goods and services Cathay Biotech provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Cathay Biotech financial statement analysis. It represents the amount of money remaining after all of Cathay Biotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from Cathay Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cathay Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 56.8 M, whereas Selling General Administrative is forecasted to decline to about 83.2 M.

	2022	2023	2024	2025 (projected)
Interest Expense	20.0M	32.2M	37.0M	19.7M
Interest Income	236.8M	219.8M	252.7M	156.9M

Interest Expense Interest Income

Cathay Biotech fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Intangible Assets	Property Plant And Equipment Net	Property Plant And Equipment Gross
Total Assets		-0.9	0.73	0.98	0.98	0.63	0.9	0.91	0.92	0.65	0.88	0.92	-0.84	0.7	0.94	-0.67	0.79	0.99	0.8	0.91	0.93	0.76	0.95	0.86	0.87
Other Current Liab	-0.9		-0.47	-0.96	-0.81	-0.33	-0.97	-0.66	-0.91	-0.9	-0.84	-0.82	0.65	-0.57	-0.73	0.72	-0.54	-0.92	-0.65	-0.98	-0.71	-0.95	-0.82	-0.58	-0.58
Total Current Liabilities	0.73	-0.47		0.66	0.8	0.96	0.5	0.82	0.54	0.06	0.54	0.8	-0.77	0.49	0.78	-0.36	0.98	0.71	0.92	0.51	0.82	0.29	0.7	0.86	0.86
Total Stockholder Equity	0.98	-0.96	0.66		0.94	0.54	0.94	0.84	0.91	0.75	0.85	0.93	-0.75	0.62	0.86	-0.65	0.71	0.99	0.79	0.95	0.87	0.84	0.89	0.78	0.79
Retained Earnings	0.98	-0.81	0.8	0.94		0.72	0.82	0.97	0.87	0.52	0.84	0.92	-0.84	0.72	0.96	-0.61	0.85	0.97	0.82	0.82	0.97	0.64	0.93	0.94	0.94
Accounts Payable	0.63	-0.33	0.96	0.54	0.72		0.32	0.8	0.47	-0.07	0.5	0.7	-0.68	0.57	0.74	-0.36	0.96	0.6	0.81	0.34	0.8	0.11	0.58	0.85	0.85
Cash	0.9	-0.97	0.5	0.94	0.82	0.32		0.66	0.88	0.86	0.82	0.82	-0.74	0.5	0.75	-0.67	0.55	0.92	0.67	1.0	0.69	0.96	0.87	0.57	0.58
Non Current Assets Total	0.91	-0.66	0.82	0.84	0.97	0.8	0.66		0.79	0.33	0.79	0.84	-0.82	0.77	0.96	-0.56	0.88	0.88	0.76	0.66	0.99	0.44	0.87	0.99	0.99
Non Currrent Assets Other	0.92	-0.91	0.54	0.91	0.87	0.47	0.88	0.79		0.79	0.99	0.79	-0.81	0.85	0.89	-0.9	0.66	0.9	0.56	0.88	0.84	0.8	0.91	0.71	0.71
Long Term Debt	0.65	-0.9	0.06	0.75	0.52	-0.07	0.86	0.33	0.79		0.72	0.55	-0.4	0.45	0.45	-0.71	0.16	0.69	0.28	0.86	0.41	0.95	0.6	0.21	0.22
Net Receivables	0.88	-0.84	0.54	0.85	0.84	0.5	0.82	0.79	0.99	0.72		0.76	-0.83	0.91	0.9	-0.94	0.67	0.85	0.5	0.81	0.84	0.74	0.91	0.7	0.71
Common Stock Shares Outstanding	0.92	-0.82	0.8	0.93	0.92	0.7	0.82	0.84	0.79	0.55	0.76		-0.73	0.56	0.84	-0.56	0.82	0.94	0.88	0.85	0.88	0.7	0.83	0.82	0.82
Short Term Investments	-0.84	0.65	-0.77	-0.75	-0.84	-0.68	-0.74	-0.82	-0.81	-0.4	-0.83	-0.73		-0.72	-0.92	0.71	-0.83	-0.79	-0.67	-0.72	-0.81	-0.56	-0.95	-0.77	-0.78
Non Current Liabilities Total	0.7	-0.57	0.49	0.62	0.72	0.57	0.5	0.77	0.85	0.45	0.91	0.56	-0.72		0.84	-0.88	0.65	0.65	0.32	0.5	0.81	0.4	0.74	0.71	0.71
Inventory	0.94	-0.73	0.78	0.86	0.96	0.74	0.75	0.96	0.89	0.45	0.9	0.84	-0.92	0.84		-0.72	0.86	0.9	0.7	0.74	0.97	0.55	0.96	0.92	0.93
Other Current Assets	-0.67	0.72	-0.36	-0.65	-0.61	-0.36	-0.67	-0.56	-0.9	-0.71	-0.94	-0.56	0.71	-0.88	-0.72		-0.51	-0.65	-0.28	-0.67	-0.63	-0.67	-0.74	-0.46	-0.47
Total Liab	0.79	-0.54	0.98	0.71	0.85	0.96	0.55	0.88	0.66	0.16	0.67	0.82	-0.83	0.65	0.86	-0.51		0.76	0.87	0.56	0.88	0.35	0.77	0.9	0.9
Net Invested Capital	0.99	-0.92	0.71	0.99	0.97	0.6	0.92	0.88	0.9	0.69	0.85	0.94	-0.79	0.65	0.9	-0.65	0.76		0.81	0.93	0.91	0.79	0.91	0.84	0.84
Short Long Term Debt	0.8	-0.65	0.92	0.79	0.82	0.81	0.67	0.76	0.56	0.28	0.5	0.88	-0.67	0.32	0.7	-0.28	0.87	0.81		0.69	0.77	0.52	0.68	0.79	0.79
Total Current Assets	0.91	-0.98	0.51	0.95	0.82	0.34	1.0	0.66	0.88	0.86	0.81	0.85	-0.72	0.5	0.74	-0.67	0.56	0.93	0.69		0.7	0.96	0.86	0.58	0.59
Capital Stock	0.93	-0.71	0.82	0.87	0.97	0.8	0.69	0.99	0.84	0.41	0.84	0.88	-0.81	0.81	0.97	-0.63	0.88	0.91	0.77	0.7		0.5	0.87	0.97	0.97
Net Working Capital	0.76	-0.95	0.29	0.84	0.64	0.11	0.96	0.44	0.8	0.95	0.74	0.7	-0.56	0.4	0.55	-0.67	0.35	0.79	0.52	0.96	0.5		0.72	0.34	0.35
Intangible Assets	0.95	-0.82	0.7	0.89	0.93	0.58	0.87	0.87	0.91	0.6	0.91	0.83	-0.95	0.74	0.96	-0.74	0.77	0.91	0.68	0.86	0.87	0.72		0.81	0.81
Property Plant And Equipment Net	0.86	-0.58	0.86	0.78	0.94	0.85	0.57	0.99	0.71	0.21	0.7	0.82	-0.77	0.71	0.92	-0.46	0.9	0.84	0.79	0.58	0.97	0.34	0.81		1.0
Property Plant And Equipment Gross	0.87	-0.58	0.86	0.79	0.94	0.85	0.58	0.99	0.71	0.22	0.71	0.82	-0.78	0.71	0.93	-0.47	0.9	0.84	0.79	0.59	0.97	0.35	0.81	1.0

Click cells to compare fundamentals

Cathay Biotech Account Relationship Matchups

Cathay Biotech fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	12.1B	16.2B	17.8B	18.8B	21.7B	15.6B
Other Current Liab	2.2M	1.7M	2.2M	5.9M	5.3M	4.3M
Total Current Liabilities	434.8M	1.2B	1.4B	3.4B	3.9B	4.1B
Total Stockholder Equity	10.4B	10.7B	10.9B	11.2B	12.8B	10.5B
Retained Earnings	1.2B	1.4B	1.8B	2.1B	2.4B	1.6B
Accounts Payable	353.2M	302.3M	1.1B	1.7B	1.9B	2.0B
Cash	5.7B	9.6B	6.3B	5.4B	6.2B	6.0B
Non Current Assets Total	3.7B	4.8B	9.4B	11.3B	13.0B	7.1B
Non Currrent Assets Other	572.3M	938.5M	1.8B	876.5M	1.0B	918.8M
Net Receivables	188.1M	259.3M	390.4M	243.3M	279.7M	271.7M
Non Current Liabilities Total	216.0M	293.0M	1.4B	650.5M	748.1M	621.3M
Inventory	775.1M	1.2B	1.6B	1.5B	1.7B	1.3B
Other Current Assets	296.8M	231.9M	80.9M	287.2M	258.5M	193.1M
Total Liab	650.7M	1.5B	2.8B	4.1B	4.7B	4.9B
Net Invested Capital	10.4B	11.4B	12.1B	12.9B	14.9B	11.4B
Total Current Assets	8.4B	11.4B	8.5B	7.6B	8.7B	8.5B
Net Working Capital	8.0B	10.2B	7.1B	4.2B	4.8B	6.8B
Intangible Assets	228.4M	768.5M	777.9M	703.9M	809.4M	596.1M

Currently Active Assets on Macroaxis

CRM	Salesforce
C	Citigroup
GM	General Motors
WD	Walker Dunlop
MSFT	Microsoft

Other Information on Investing in Cathay Stock

Balance Sheet is a snapshot of the financial position of Cathay Biotech at a specified time, usually calculated after every quarter, six months, or one year. Cathay Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cathay Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cathay currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cathay Cost Of Revenue vs Net Income Analysis

Cost Of Revenue vs Net Income

Cost Of Revenue vs Net Income Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Net Income

Cathay Biotech fundamental ratios Correlations

Cathay Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cathay Biotech fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Cathay Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Net Invested Capital	+ 0.99	Total Assets
Net Invested Capital	+ 0.99	Total Stockholder Equity
Capital Stock	+ 0.99	Non Current Assets Total
Property Plant And Equipment Net	+ 0.99	Non Current Assets Total

Total Current Assets	- 0.98	Other Current Liab
Cash	- 0.97	Other Current Liab
Total Stockholder Equity	- 0.96	Other Current Liab
Intangible Assets	- 0.95	Short Term Investments
Net Working Capital	- 0.95	Other Current Liab
Other Current Assets	- 0.94	Net Receivables